Company
Geneos Therapeutics
Exquisitely Personalized Immunotherapies
Also known as Geneos Therapeutics, Inc
- Business model
- B2B
- Legal name
- Geneos Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Bringing Personalized Immunotherapies for Cancer to the world, one patient at a time. Geneos Therapeutics, a Phase 2b biotherapeutics company, is developing DNA-based personalized immunotherapies for cancer (PICs) which may serve an important role as a new treatment paradigm for cancer. The company uses its proprietary GT-EPIC™ platform to provide every cancer patient with a ... Read more
Funding snapshot
- Total raised
- $37.1MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $5M2023-03-31
Funding rounds
- Round, 2023
- $5M2023-03-31, SEC form D sold, 1 investor
- Round, 2022
- $17.2M2022-03-21, SEC form D sold, 9 investors
- Round, 2020
- $10.4M2020-11-12, SEC form D sold, 4 investors
- Round, 2019
- $4.5M2019-02-21, SEC form D sold, 3 investors
Loading relationship preview